Jennifer Loh, MD
Show Description +
Jennifer Loh, MD, reviews common concerns and fears that patients express about presbyopia and how she explains its pathophysiology and treatment options to mitigate symptoms. She highlights how innovations like Qlosi (pilocarpine HCL ophthalmic solution 0.4%, Orasis Pharmaceuticals) stand out from other treatments.
Posted: 5/08/2025
Jennifer Loh, MD
Jennifer Loh, MD, reviews common concerns and fears that patients express about presbyopia and how she explains its pathophysiology and treatment options to mitigate symptoms. She highlights how innovations like Qlosi (pilocarpine HCL ophthalmic solution 0.4%, Orasis Pharmaceuticals) stand out from other treatments.
Posted: 5/08/2025
About Orasis Pharmaceuticals
ORASIS (OR-uh-sis) Pharmaceuticals is an emerging ophthalmic pharmaceutical company, with offices in the US and Israel, focused on developing an innovative solution for the treatment of presbyopia symptoms. Orasis’ novel proprietary formulation of low dose pilocarpine and a proprietary vehicle was purposefully designed with the patient in mind to achieve an optimal balance among efficacy, safety, and comfort.
The name Orasis has its roots in the Greek language, where it carries a literal translation of “good vision or sight.” Beyond this, however, as good vision in its positive mental/philosophical meaning — and this speaks to our aspiration as a company to develop pharmaceutical drugs that improve vision and quality of life for millions of people around the world.
Visit us online: orasis-pharma.com
Follow Orasis Pharmaceuticals